Company
Argonaute RNA
Dual-silencing RNAi to cut heart-attack and stroke risk.
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Dual-silencing RNAi to cut heart-attack and stroke risk.
Loading relationship preview